Comments
Drug firm Divis Laboratories today reported 4.37 per cent rise in net profit to Rs 174.71 crore for the quarter ended June 30, 2013, on account of robust sales and increase in forex gains.
The company had posted a net profit of Rs 167.38 crore for the corresponding period previous fiscal, Divis Laboratories said in a filing to BSE.
Total income of the company also rose to Rs 517.15 crore for the quarter under consideration from Rs 469.51 crore for the year ago period, it added.
“Forex gain for the current quarter amounted to Rs 43 crore as against a gain of Rs 30 crore during the corresponding quarter last year,” Divis Laboratories said.
Established in 1990 the company’s primarily focuses on Active Pharma Ingredients (APIs) & Intermediates.
The company also undertakes full-time equivalent (FTE)/ Contract Research on process development for discovering new compounds for leading multi-national companies across the world and partners with them for the supply of APIs.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.